U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07521800) titled 'Remote ECG Monitoring Post TAVI' on Nov. 24, 2025.
Brief Summary: The DRAGON TAVI study is a multicenter, prospective, open, randomised trial, which will enrol 250 patients, randomized 1:1 to the study group (continuous 30-day ECG monitoring with visits triggered by ECG findings) and standard care (ie. control group, which will receive the standard post op 24-48h ECG monitoring and a regular follow-up visit with standard ECG within 30 days). The duration of the study is 12 months ± 1 month.
Study Start Date: Dec. 01, 2023
Study Type: INTERVENTIONAL
Condition:
TAVI(Transcatheter Aortic Valve Implantation)
Remote Monitoring...